![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
High Incidences of Acute and Chronic Graft-Versus-Host Disease after
Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa,
Busulfan, and Fludarabine Pretransplant Conditioning.
Acta Haematol. 2023;146:88-91.
PubMed
Molecular genetics and management of world health organization defined
atypical chronic myeloid leukemia.
Ann Hematol. 2023 Feb 3. doi: 10.1007/s00277-023-05106.
PubMed
Abstract available
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for
patients with acute myeloid leukemia: retrospective analysis of an electronic
medical record database in the United States.
Ann Hematol. 2023 Feb 3. doi: 10.1007/s00277-023-05109.
PubMed
Abstract available
Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia.
Ann Hematol. 2023;102:487-489.
PubMed
Molecular response patterns in relapsed/refractory AML patients treated with
selinexor and chemotherapy.
Ann Hematol. 2023;102:323-328.
PubMed
Abstract available
The association between nutritional risk index and ICU outcomes across
hematologic malignancy patients with acute respiratory failure.
Ann Hematol. 2023;102:439-445.
PubMed
Abstract available
The KMT2A rearrangement is an early event prior to KMT2A-PTD in AML patients with
both molecular aberrations.
Ann Hematol. 2023;102:495-497.
PubMed
AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR
axis in chronic myeloid leukemia cells.
Biochem Pharmacol. 2023 Jan 28:115442. doi: 10.1016/j.bcp.2023.115442.
PubMed
Abstract available
Single-cell genomics in AML: extending the frontiers of AML research.
Blood. 2023;141:345-355.
PubMed
Abstract available
Introduction to a review series on single-cell genomics: getting ready for
clinical impact in leukemia and myeloid neoplasms.
Blood. 2023;141:323-325.
PubMed
Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of
the revised ELN 2022 classification.
Blood. 2023;141:433-435.
PubMed
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients
with acute myeloid leukemia.
Blood. 2023 Jan 30:blood.2022017333. doi: 10.1182/blood.2022017333.
PubMed
Abstract available
ERGonomics for EVI1 acute myeloid leukemia.
Blood. 2023;141:441-443.
PubMed
The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid
leukemia in cooperation with mutant TP53.
Blood. 2023 Feb 3:blood.2022017273. doi: 10.1182/blood.2022017273.
PubMed
Abstract available
Fludarabine or cyclophosphamide in combination with total body irradiation as
myeloablative conditioning prior to allogeneic hematopoietic cell transplantation
for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party
of the EB
Bone Marrow Transplant. 2023 Feb 1. doi: 10.1038/s41409-023-01917.
PubMed
Abstract available
Prediction of survival with lower intensity therapy among older patients with
acute myeloid leukemia.
Cancer. 2023 Jan 30. doi: 10.1002/cncr.34609.
PubMed
Abstract available
Mutational Profile, Outcomes, and Impact of Allogeneic Hematopoietic Stem Cell
Transplantation in Adult Patients with Acute Myeloid Leukemia and Inconclusive
Cytogenetic Analysis.
Eur J Haematol. 2023 Feb 2. doi: 10.1111/ejh.13940.
PubMed
Abstract available
Isolated relapse of plasma cell leukemia in the central nervous systems: a case
report and literature review.
Int J Hematol. 2023 Feb 3. doi: 10.1007/s12185-023-03545.
PubMed
Abstract available
The miR-106b-25 cluster mediates drug resistance in myeloid leukaemias by
inactivating multiple apoptotic genes.
Int J Hematol. 2023;117:236-250.
PubMed
Abstract available
Validation of the iATL-PI prognostic index in therapeutic decision-making for
patients with smoldering and chronic ATL: a multicenter study.
Int J Hematol. 2023;117:206-215.
PubMed
Abstract available
Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt
lymphoma occurring 9 years after allogeneic transplantation.
Int J Hematol. 2023;117:287-292.
PubMed
Abstract available
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute
Lymphoblastic Leukemia and Lymphoma.
J Pediatr Hematol Oncol. 2023 Jan 12. doi: 10.1097/MPH.0000000000002619.
PubMed
Abstract available
Safety and Efficacy of Alendronate to Treat Osteopenia in Children During Therapy
for Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of Sequential
Outcomes.
J Pediatr Hematol Oncol. 2022 Dec 13. doi: 10.1097/MPH.0000000000002606.
PubMed
Abstract available
Low Expression of BRCA1 as a Potential Relapse Predictor in B-Cell Acute
Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2022 Nov 21. doi: 10.1097/MPH.0000000000002595.
PubMed
Abstract available
Physical Inactivity as an Early Sign of Frailty in Young Adult Survivors of
Childhood Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2022 Nov 14. doi: 10.1097/MPH.0000000000002586.
PubMed
Abstract available
Disseminated Cunninghamella Elegans Infection Diagnosed by mNGS During Induction
Therapy in a Child With Intermediate-risk Acute Lymphoblastic Leukemia: A Case
Report and Review of Literature.
J Pediatr Hematol Oncol. 2022 Oct 24. doi: 10.1097/MPH.0000000000002577.
PubMed
Abstract available
Clone Dynamics and Its Application for the Diagnosis of Enzootic Bovine Leukosis.
J Virol. 2023;97:e0154222.
PubMed
Abstract available
Clinical and molecular characteristics associated with Vitamin C deficiency in
myeloid malignancies; real world data from a prospective cohort.
Leuk Res. 2023;125:107001.
PubMed
Abstract available
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing
allogeneic hematopoietic stem cell transplantation.
Leuk Res. 2022;125:107004.
PubMed
Abstract available
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D
rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working
Group.
Leukemia. 2023;37:212-216.
PubMed
Loss of bisecting GlcNAcylation on MCAM of bone marrow stoma determined
pro-tumoral niche in MDS/AML.
Leukemia. 2023;37:113-121.
PubMed
Abstract available
Optical Genome Mapping in MDS and AML as tool for structural variant
profiling-comment and data update on Yang et al.: "High-resolution structural
variant profiling of myelodysplastic syndromes by optical genome mapping uncovers
cryptic aberrations of
Leukemia. 2023;37:248-249.
PubMed
Improved survival and MRD remission with blinatumomab vs. chemotherapy in
children with first high-risk relapse B-ALL.
Leukemia. 2023;37:222-225.
PubMed
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the
international trial AIEOP-BFM ALL 2009.
Leukemia. 2023;37:72-78.
PubMed
Abstract available
A pro B cell population forms the apex of the leukemic hierarchy in
Hoxa9/Meis1-dependent AML.
Leukemia. 2023;37:79-90.
PubMed
Abstract available
Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute
lymphoblastic leukaemia.
Leukemia. 2023;37:47-52.
PubMed
Management of children and adolescents with chronic myeloid leukemia in blast
phase: International pediatric CML expert panel recommendations.
Leukemia. 2023 Jan 27. doi: 10.1038/s41375-023-01822.
PubMed
Abstract available
The genomic landscape and clonal evolutionary trajectory of classical hairy cell
leukemia.
Leukemia. 2023 Jan 28. doi: 10.1038/s41375-023-01823.
PubMed
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with
relapsed or refractory chronic lymphocytic leukemia.
Leukemia. 2023 Jan 30. doi: 10.1038/s41375-023-01830.
PubMed
Abstract available
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously
treated with at least two tyrosine kinase inhibitors: longer-term follow-up of
ASCEMBL.
Leukemia. 2023 Jan 30. doi: 10.1038/s41375-023-01829.
PubMed
Abstract available
KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A
sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.
Leukemia. 2023 Jan 31. doi: 10.1038/s41375-023-01833.
PubMed
Abstract available
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic
role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
Oncogene. 2021;40:2697-2710.
PubMed
Abstract available
Bovine leukemia virus encoded blv-miR-b4-3p microRNA is associated with reduced
expression of anti-oncogenic gene in vivo.
PLoS One. 2023;18:e0281317.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by